Skip to content
Menu

Eli Lilly and Company LLY.TO

Full chart Compare
Set alert

Price alert · LLY.TO

All alert types
50.90 CAD -0.48 (-0.93%)

As ofNov 16, 2026, 3:58 PM EST

50.76 Day range 52.45
30.67 52-week range 52.45
YTD
+30.25%
1 year
+30.25%
Market cap
1.66T
Profit margin
33.53%
EPS (ttm)
1.09
P/E ratio
46.70
YTD return
+30.25%
1-year return
+30.25%
Volume
68.10K
Avg volume
87.81K
Open
51.75
Previous close
51.38
Day's range
50.76 – 52.45
52-week range
30.67 – 52.45

5D +2.12 (+4.34%)

495051MonTueWedThuFri51.00

Key statistics

50-day average
44.28
200-day average
39.84
Enterprise value
1.15T
PEG ratio
0.42
Price / book
30.79
Total debt
62
Return on equity
92.58%

About Eli Lilly and Company

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
US
Employees
50,000
Website
lilly.com

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on LLY.TO — it syncs with the Stock Master app.